Exagen announces resale of up to 1.15M shares
Source: SeekingAlpha
2025-06-20 16:30:54 ET
More on Exagen
- Exagen Inc. (XGN) Q1 2025 Earnings Call Transcript
- Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability
- Exagen prices public offering of common stock
- Exagen prices public offering of common stock
- Seeking Alpha’s Quant Rating on Exagen
Read the full article on Seeking Alpha
For further details see:
Exagen announces resale of up to 1.15M shares
Exagen Inc.
NASDAQ: XGN
XGN Trading
-8.28% G/L:
$3.12 Last:
260,124 Volume:
$3.17 Open:
XGN Latest News
February 24, 2026 09:00:00 am
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
XGN Stock Data
$80,000,739
13,869,817
3.15%
15
N/A
Medical Diagnostics & Screening
Healthcare
US
Vista
